QNRX - Balance Sheet - Quoin Pharmaceuticals, Ltd.

Current Liabilities	4.18 M
Accounts Payable	906 K
Short-Term Debt	0
Other Current Liabilities	3.28 M
Non-Current Liabilities	2.32 M
Long-Term Debt	0
Other Non-Current Liabilities	2.32 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016	Dec-2015
ASSETS
Cash & Cash Equivalents	3.6	2.4	2.9	7.5	0.3	5.2	4.8	4.0	1.6	1.0
Short Term Investments	10.4	8.3	10.0	0	0	0	0	4.0	6.4	2.0
Receivables	0	0	0	0	0	77.3 K	57.8 K	70.6 K	0.2	48.1 K
Inventory	0	0	0	0	0	1	0	1	1	0
Other Current Assets	0	0.6	0.5	0.7	0.1	58.5 K	0.2	0.2	0.2	57.8 K
Total Current Assets	14.9	11.3	13.4	8.5	0.5	5.4	5.0	8.2	8.4	3.1
PP&E	0	0	0	0	1.9	0.7	0.4	0.4	0.4	0.3
Intangible Assets	0.5	0.6	0.7	0.8	0.9	1.0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0.1	0.1	0.1	36.4 K	5.14 K
Other Long Term Assets	0.3	0.3	0.4	50 K	(1.9)	1.02 K	0	1	0	1
Other Assets	0	0	0	0	0	1	1	0	1	1
Total Assets	15.7	12.2	14.5	9.4	1.4	6.2	5.5	8.7	8.8	3.4
LIABILITIES
Accounts Payable	0.9	0.5	0.6	0.9	0	45.7 K	0.2	0.5	0.3	0.1
Short Term Debt	0	0	0	743.8	1.2	0.1	0	0	15.1 K	0
Other Current Liabilities	3.2	3.0	2.8	(740.4)	6.6	0.9	1.1	0.7	0.5	0.6
Total Current Liabilities	4.2	3.6	3.5	8.7	8.0	1.1	1.3	1.2	0.9	0.7
Long Term Debt	0	0	0	4.1	0	0.2	0	0	0	0
Deferred Tax Income	0	0	0	0	0	0	0	0	0	0
Other Liabilities	2.3	2.9	3.5	7 028.6	0	0.6	0.5	2.1	0.5	0
Total Liabilities	6.5	6.5	7.1	8.7	8.0	1.9	1.8	3.3	1.4	0.7
EQUITY
Common Stock	0	0	0	0	0	100	0	0	0	0
Retained Earnings	(55 165.8)	(46.2)	(37.5)	(28.1)	(6.6)	(29.2)	(22.5)	(18.4)	(9.3)	(5.2)
Other Accumulative Comprehensive Income/Loss	0	0	0	0	5.1	4.8	3.3	2.7	1.6	1.0
Total Equity	9 204.7	5.7	7.4	0.7	(6.6)	4.3	3.7	5.4	7.4	2.7
Total Liabilities and Equity	15.7	12.2	14.5	9.4	1.4	6.2	5.5	8.7	8.8	3.4
SHARES OUTSTANDING
Common Shares Outstanding	4.7	0.9	0.4	26.4 K	20 K	3.54 K	2.16 K	1.87 K	1.52 K	1.24 K

Free